Treat-and-Extend vs. Pro Re Nata Regimen of Ranibizumab for Diabetic Macular Edema—A Two-Year Matched Comparative Study

PURPOSE: To compare 2-year treatment outcomes of ranibizumab using treat-and-extend (T&E) or pro re nata (PRN) regimens for diabetic macular edema (DME) in clinical settings. METHODS: We retrospectively enrolled 34 patients (34 eyes) with DME treated with ranibizumab using the T&E regimen, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Tso-Ting, Chen, Ta-Ching, Yang, Chang-Hao, Yang, Chung-May, Ho, Tzyy-Chang, Hsieh, Yi-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821911/
https://www.ncbi.nlm.nih.gov/pubmed/35145975
http://dx.doi.org/10.3389/fmed.2021.781421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821911/
https://www.ncbi.nlm.nih.gov/pubmed/35145975
http://dx.doi.org/10.3389/fmed.2021.781421

Ejemplares similares